80 related articles for article (PubMed ID: 24469723)
1. Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report.
Kolacinska A; Morawiec J; Fendler W; Malachowska B; Morawiec Z; Szemraj J; Pawlowska Z; Chowdhury D; Choi YE; Kubiak R; Pakula L; Zawlik I
Mol Biol Rep; 2014 May; 41(5):2851-7. PubMed ID: 24469723
[TBL] [Abstract][Full Text] [Related]
2. Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
Al-Khanbashi M; Caramuta S; Alajmi AM; Al-Haddabi I; Al-Riyami M; Lui WO; Al-Moundhri MS
PLoS One; 2016; 11(4):e0152032. PubMed ID: 27064979
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatment.
Sueta A; Fujiki Y; Goto-Yamaguchi L; Tomiguchi M; Yamamoto-Ibusuki M; Iwase H; Yamamoto Y
Oncol Lett; 2021 Dec; 22(6):819. PubMed ID: 34671433
[TBL] [Abstract][Full Text] [Related]
4. The Role of Circulating MicroRNAs in the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer in the Indian Population.
Tripathi S; Mathaiyan J; Kayal S; Nachiappa Ganesh R
Cureus; 2024 May; 16(5):e59553. PubMed ID: 38832155
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
[TBL] [Abstract][Full Text] [Related]
6. Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients.
Kolacinska A; Morawiec J; Pawlowska Z; Szemraj J; Szymanska B; Malachowska B; Morawiec Z; Morawiec-Sztandera A; Pakula L; Kubiak R; Zawlik I
DNA Cell Biol; 2014 Sep; 33(9):624-9. PubMed ID: 24865188
[TBL] [Abstract][Full Text] [Related]
7. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
[TBL] [Abstract][Full Text] [Related]
8. Predicting response to preoperative chemotherapy agents by identifying drug action on modeled microRNA regulation networks.
Zhu L; Liu J; Liang F; Rayner S; Xiong J
PLoS One; 2014; 9(5):e98140. PubMed ID: 24848634
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.
Avery-Kiejda KA; Braye SG; Mathe A; Forbes JF; Scott RJ
BMC Cancer; 2014 Jan; 14():51. PubMed ID: 24479446
[TBL] [Abstract][Full Text] [Related]
10. LINC01140 Hinders the Development of Breast Cancer Through Targeting miR-200b-3p to Downregulate DMD.
Peng G; Yan J; Shi P; Li H
Cell Transplant; 2023; 32():9636897231211202. PubMed ID: 38009192
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype.
Tariq M; Richard V; Kerin MJ
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002007
[TBL] [Abstract][Full Text] [Related]
12. Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review.
van den Ende NS; Nguyen AH; Jager A; Kok M; Debets R; van Deurzen CHM
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769287
[TBL] [Abstract][Full Text] [Related]
13. miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Zhang Z; Zhang H; Yu J; Xu L; Pang X; Xiang Q; Liu Q; Cui Y
Breast Cancer Res Treat; 2022 Aug; 194(3):483-505. PubMed ID: 35727379
[TBL] [Abstract][Full Text] [Related]
14. Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness.
Darbeheshti F; Kadkhoda S; Keshavarz-Fathi M; Razi S; Bahramy A; Mansoori Y; Rezaei N
BMC Cancer; 2022 Jun; 22(1):668. PubMed ID: 35715772
[TBL] [Abstract][Full Text] [Related]
15. Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?
Ryspayeva D; Halytskiy V; Kobyliak N; Dosenko I; Fedosov A; Inomistova M; Drevytska T; Gurianov V; Sulaieva O
Discov Oncol; 2022 Jun; 13(1):43. PubMed ID: 35668332
[TBL] [Abstract][Full Text] [Related]
16. Alkylating anticancer agents and their relations to microRNAs.
Biersack B
Cancer Drug Resist; 2019; 2(1):1-17. PubMed ID: 35582140
[TBL] [Abstract][Full Text] [Related]
17. Regulatory functions of miR‑200b‑3p in tumor development (Review).
Chen S; Tu Y; Yuan H; Shi Z; Guo Y; Gong W; Tu S
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35322861
[TBL] [Abstract][Full Text] [Related]
18. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
Paul U; Banerjee S
Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
[TBL] [Abstract][Full Text] [Related]
19. miRNA and lncRNA Expression Networks Modulate Cell Cycle and DNA Repair Inhibition in Senescent Prostate Cells.
da Silveira WA; Renaud L; Hazard ES; Hardiman G
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205253
[TBL] [Abstract][Full Text] [Related]
20. Novel cytoplasmic lncRNA IKBKBAS promotes lung adenocarcinoma metastasis by upregulating IKKβ and consequential activation of NF-κB signaling pathway.
Xing Y; Lin Y; Zhang Y; Hu J; Liu J; Tian Y; Zhao J; Chen W; Han B
Cell Death Dis; 2021 Oct; 12(11):1004. PubMed ID: 34702815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
